Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Randomized Controlled Comparative Study of Gene-Activated Osteoplastic Material "Histograft" in Patients With Degenerative Diseases of the Lumbar and Cervical Spine

NCT06365307 is registered in ClinicalTrials.gov with Histograft Co., Ltd. as lead sponsor.

NCT NCT06365307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06365307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Randomized Controlled Comparative Study of Gene-Activated Osteoplastic Material "Histograft" in Patients With Degenerative Diseases of the Lumbar and Cervical Spine
Lead sponsor
Histograft Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
November 13, 2023
Completion date
April 30, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomechanical lesion, unspecified, cervical disc disorder with radiculopathy, lumbar and other intervertebral disc disorders with radiculopathy, spinal stenosis